Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Phosphodiesterase Inhibitor Market Report 2016

  • QYR679041
  • 122 Pages
  • September 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Phosphodiesterase Inhibitor

Revenue, means the sales value of Phosphodiesterase Inhibitor

This report studies sales (consumption) of Phosphodiesterase Inhibitor in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Actelion Pharmaceuticals Ltd.

United Therapeutics Corporation

Gilead sciences

Bayer AG

SteadyMed Ltd.

GlaxoSmithKline plc

Pfizer Inc.

Reata Pharmaceuticals Inc.

Arena Pharmaceuticals Inc.

Merck & Co. Inc

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by applications, this report focuses on sales, market share and growth rate of Phosphodiesterase Inhibitor in each application, can be divided into

Health care

Clinic

Hospital

Table of Contents

United States Phosphodiesterase Inhibitor Market Report 2016

1 Phosphodiesterase Inhibitor Overview

1.1 Product Overview and Scope of Phosphodiesterase Inhibitor

1.2 Classification of Phosphodiesterase Inhibitor

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Phosphodiesterase Inhibitor

1.3.1 Health care

1.3.2 Clinic

1.3.3 Hospital

1.4 USA Market Size Sales (Value) and Revenue (Volume) of Phosphodiesterase Inhibitor (2011-2021)

1.4.1 USA Phosphodiesterase Inhibitor Sales and Growth Rate (2011-2021)

1.4.2 USA Phosphodiesterase Inhibitor Revenue and Growth Rate (2011-2021)

2 USA Phosphodiesterase Inhibitor Competition by Manufacturers

2.1 USA Phosphodiesterase Inhibitor Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Phosphodiesterase Inhibitor Revenue and Share by Manufactures (2015 and 2016)

2.3 USA Phosphodiesterase Inhibitor Average Price by Manufactures (2015 and 2016)

2.4 Phosphodiesterase Inhibitor Market Competitive Situation and Trends

2.4.1 Phosphodiesterase Inhibitor Market Concentration Rate

2.4.2 Phosphodiesterase Inhibitor Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 USA Phosphodiesterase Inhibitor Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 USA Phosphodiesterase Inhibitor Sales and Market Share by Type (2011-2016)

3.2 USA Phosphodiesterase Inhibitor Revenue and Market Share by Type (2011-2016)

3.3 USA Phosphodiesterase Inhibitor Price by Type (2011-2016)

3.4 USA Phosphodiesterase Inhibitor Sales Growth Rate by Type (2011-2016)

4 USA Phosphodiesterase Inhibitor Sales (Volume) by Application (2011-2016)

4.1 USA Phosphodiesterase Inhibitor Sales and Market Share by Application (2011-2016)

4.2 USA Phosphodiesterase Inhibitor Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 USA Phosphodiesterase Inhibitor Manufacturers Profiles/Analysis

5.1 Actelion Pharmaceuticals Ltd.

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Phosphodiesterase Inhibitor Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Actelion Pharmaceuticals Ltd. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 United Therapeutics Corporation

5.2.2 Phosphodiesterase Inhibitor Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 United Therapeutics Corporation Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Gilead sciences

5.3.2 Phosphodiesterase Inhibitor Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Gilead sciences Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Bayer AG

5.4.2 Phosphodiesterase Inhibitor Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Bayer AG Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 SteadyMed Ltd.

5.5.2 Phosphodiesterase Inhibitor Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 SteadyMed Ltd. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 GlaxoSmithKline plc

5.6.2 Phosphodiesterase Inhibitor Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 GlaxoSmithKline plc Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Pfizer Inc.

5.7.2 Phosphodiesterase Inhibitor Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Pfizer Inc. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Reata Pharmaceuticals Inc.

5.8.2 Phosphodiesterase Inhibitor Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Reata Pharmaceuticals Inc. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Arena Pharmaceuticals Inc.

5.9.2 Phosphodiesterase Inhibitor Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Arena Pharmaceuticals Inc. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Merck & Co. Inc

5.10.2 Phosphodiesterase Inhibitor Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Merck & Co. Inc Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

6 Phosphodiesterase Inhibitor Manufacturing Cost Analysis

6.1 Phosphodiesterase Inhibitor Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Phosphodiesterase Inhibitor

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Phosphodiesterase Inhibitor Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Phosphodiesterase Inhibitor Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 USA Phosphodiesterase Inhibitor Market Forecast (2016-2021)

10.1 USA Phosphodiesterase Inhibitor Sales, Revenue Forecast (2016-2021)

10.2 USA Phosphodiesterase Inhibitor Sales Forecast by Type (2016-2021)

10.3 USA Phosphodiesterase Inhibitor Sales Forecast by Application (2016-2021)

10.4 Phosphodiesterase Inhibitor Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Phosphodiesterase Inhibitor

Table Classification of Phosphodiesterase Inhibitor

Figure USA Sales Market Share of Phosphodiesterase Inhibitor by Type in 2015

Table Application of Phosphodiesterase Inhibitor

Figure USA Sales Market Share of Phosphodiesterase Inhibitor by Application in 2015

Figure Health care Examples

Figure Clinic Examples

Figure Hospital Examples

Figure USA Phosphodiesterase Inhibitor Sales and Growth Rate (2011-2021)

Figure USA Phosphodiesterase Inhibitor Revenue and Growth Rate (2011-2021)

Table USA Phosphodiesterase Inhibitor Sales of Key Manufacturers (2015 and 2016)

Table USA Phosphodiesterase Inhibitor Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Phosphodiesterase Inhibitor Sales Share by Manufacturers

Figure 2016 Phosphodiesterase Inhibitor Sales Share by Manufacturers

Table USA Phosphodiesterase Inhibitor Revenue by Manufacturers (2015 and 2016)

Table USA Phosphodiesterase Inhibitor Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Phosphodiesterase Inhibitor Revenue Share by Manufacturers

Table 2016 USA Phosphodiesterase Inhibitor Revenue Share by Manufacturers

Table USA Market Phosphodiesterase Inhibitor Average Price of Key Manufacturers (2015 and 2016)

Figure USA Market Phosphodiesterase Inhibitor Average Price of Key Manufacturers in 2015

Figure Phosphodiesterase Inhibitor Market Share of Top 3 Manufacturers

Figure Phosphodiesterase Inhibitor Market Share of Top 5 Manufacturers

Table USA Phosphodiesterase Inhibitor Sales by Type (2011-2016)

Table USA Phosphodiesterase Inhibitor Sales Share by Type (2011-2016)

Figure USA Phosphodiesterase Inhibitor Sales Market Share by Type in 2015

Table USA Phosphodiesterase Inhibitor Revenue and Market Share by Type (2011-2016)

Table USA Phosphodiesterase Inhibitor Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Phosphodiesterase Inhibitor by Type (2011-2016)

Table USA Phosphodiesterase Inhibitor Price by Type (2011-2016)

Figure USA Phosphodiesterase Inhibitor Sales Growth Rate by Type (2011-2016)

Table USA Phosphodiesterase Inhibitor Sales by Application (2011-2016)

Table USA Phosphodiesterase Inhibitor Sales Market Share by Application (2011-2016)

Figure USA Phosphodiesterase Inhibitor Sales Market Share by Application in 2015

Table USA Phosphodiesterase Inhibitor Sales Growth Rate by Application (2011-2016)

Figure USA Phosphodiesterase Inhibitor Sales Growth Rate by Application (2011-2016)

Table Actelion Pharmaceuticals Ltd. Basic Information List

Table Actelion Pharmaceuticals Ltd. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Actelion Pharmaceuticals Ltd. Phosphodiesterase Inhibitor Sales Market Share (2011-2016)

Table United Therapeutics Corporation Basic Information List

Table United Therapeutics Corporation Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Table United Therapeutics Corporation Phosphodiesterase Inhibitor Sales Market Share (2011-2016)

Table Gilead sciences Basic Information List

Table Gilead sciences Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Table Gilead sciences Phosphodiesterase Inhibitor Sales Market Share (2011-2016)

Table Bayer AG Basic Information List

Table Bayer AG Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bayer AG Phosphodiesterase Inhibitor Sales Market Share (2011-2016)

Table SteadyMed Ltd. Basic Information List

Table SteadyMed Ltd. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Table SteadyMed Ltd. Phosphodiesterase Inhibitor Sales Market Share (2011-2016)

Table GlaxoSmithKline plc Basic Information List

Table GlaxoSmithKline plc Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Table GlaxoSmithKline plc Phosphodiesterase Inhibitor Sales Market Share (2011-2016)

Table Pfizer Inc. Basic Information List

Table Pfizer Inc. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Table Pfizer Inc. Phosphodiesterase Inhibitor Sales Market Share (2011-2016)

Table Reata Pharmaceuticals Inc. Basic Information List

Table Reata Pharmaceuticals Inc. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Table Reata Pharmaceuticals Inc. Phosphodiesterase Inhibitor Sales Market Share (2011-2016)

Table Arena Pharmaceuticals Inc. Basic Information List

Table Arena Pharmaceuticals Inc. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Table Arena Pharmaceuticals Inc. Phosphodiesterase Inhibitor Sales Market Share (2011-2016)

Table Merck & Co. Inc Basic Information List

Table Merck & Co. Inc Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck & Co. Inc Phosphodiesterase Inhibitor Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Phosphodiesterase Inhibitor

Figure Manufacturing Process Analysis of Phosphodiesterase Inhibitor

Figure Phosphodiesterase Inhibitor Industrial Chain Analysis

Table Raw Materials Sources of Phosphodiesterase Inhibitor Major Manufacturers in 2015

Table Major Buyers of Phosphodiesterase Inhibitor

Table Distributors/Traders List

Figure USA Phosphodiesterase Inhibitor Production and Growth Rate Forecast (2016-2021)

Figure USA Phosphodiesterase Inhibitor Revenue and Growth Rate Forecast (2016-2021)

Table USA Phosphodiesterase Inhibitor Production Forecast by Type (2016-2021)

Table USA Phosphodiesterase Inhibitor Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370